Takeaway
- The study of tumour heterogeneity explains why some cancers are especially aggressive and resistant to treatment.
- Knowledge of tumour biology and clinical trial optimization will help to reduce hard-to-treat cancer mortality.
“Why is cancer the emperor of all maladies? One of the key answers is because cancer development is...